User profiles for Martín Bäcker
MARTIN BÄCKERNYU Langone Health Verified email at nyulangone.org Cited by 1884 |
[HTML][HTML] Homologous and heterologous Covid-19 booster vaccinations
…, RC Brady, RW Frenck Jr, M Bäcker… - … England Journal of …, 2022 - Mass Medical Soc
Background Although the three vaccines against coronavirus disease 2019 (Covid-19) that
have received emergency use authorization in the United States are highly effective, …
have received emergency use authorization in the United States are highly effective, …
[PDF][PDF] Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant
The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
exhibits reduced susceptibility to vaccine-induced neutralizing antibodies, requiring a boost to …
exhibits reduced susceptibility to vaccine-induced neutralizing antibodies, requiring a boost to …
[HTML][HTML] Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
Vaccine protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection wanes over time, requiring updated boosters. In a phase 2, open-label, …
infection wanes over time, requiring updated boosters. In a phase 2, open-label, …
[HTML][HTML] Heterologous SARS-CoV-2 booster vaccinations–preliminary report
Background: While Coronavirus disease 2019 (Covid-19) vaccines are highly effective,
breakthrough infections are occurring. Booster vaccinations have recently received emergency …
breakthrough infections are occurring. Booster vaccinations have recently received emergency …
[HTML][HTML] Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants
As part of a multicenter study evaluating homologous and heterologous COVID-19 booster
vaccines, we assessed the magnitude, breadth, and short-term durability of binding and …
vaccines, we assessed the magnitude, breadth, and short-term durability of binding and …
SARS-CoV-2 variant vaccine boosters trial: preliminary analyses
Background Protection from SARS-CoV-2 vaccines wanes over time and is compounded by
emerging variants including Omicron subvariants. This study evaluated safety and …
emerging variants including Omicron subvariants. This study evaluated safety and …
Immunogenicity of the BA. 1 and BA. 4/BA. 5 severe acute respiratory syndrome coronavirus 2 bivalent boosts: preliminary results from the COVAIL randomized …
In a randomized clinical trial, we compare early neutralizing antibody responses after boosting
with bivalent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger …
with bivalent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger …
Treating COVID-19 with hydroxychloroquine (TEACH): a multicenter, double-blind randomized controlled trial in hospitalized patients
…, E Carmody, J Eapen, M Bäcker… - Open forum …, 2020 - academic.oup.com
Background Effective therapies to combat coronavirus 2019 (COVID-19) are urgently needed.
Hydroxychloroquine (HCQ) has in vitro antiviral activity against severe acute respiratory …
Hydroxychloroquine (HCQ) has in vitro antiviral activity against severe acute respiratory …
Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City
D Landman, P Kelly, M Bäcker, E Babu… - Journal of …, 2011 - academic.oup.com
Objectives Multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa have
become a global problem, often leaving the polymyxins as therapeutic agents of last resort. …
become a global problem, often leaving the polymyxins as therapeutic agents of last resort. …
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA. 1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial
We compared the serologic responses of 1 dose versus 2 doses of a variant vaccine (Moderna
mRNA-1273 Beta/Omicron BA.1 bivalent vaccine) in adults. A 2-dose boosting regimen …
mRNA-1273 Beta/Omicron BA.1 bivalent vaccine) in adults. A 2-dose boosting regimen …